Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017年版中国肝癌诊断和治疗规范解读

2018-01-30 实用肿瘤杂志.2018,33(1):1-3.

原发性肝癌乌司他丁

2017 年原发性肝癌诊疗规范( 简称规范) 已由中国国家卫生与计划生育委员会( 国家卫计委) 公布，并建议各医院遵照实施。这个规范是在2011年中国国家卫生部组织编写的《原发性肝癌诊疗规范》基础上的更新。最重要的特征是增加了肝癌分期以方便临床使用，此外这个规范主要依据来自中国学者的经验和研究结果使之更为适合中国肝癌患者的特点，而且重视多学科联合诊治。这个规范还特别强调循证医学的证据支持，依据牛津

中文标题：

2017年版中国肝癌诊断和治疗规范解读

发布机构：

发布日期：

2018-01-30

简要介绍：

2017 年原发性肝癌诊疗规范( 简称规范) 已由中国国家卫生与计划生育委员会( 国家卫计委) 公布，并建议各医院遵照实施。这个规范是在2011年中国国家卫生部组织编写的《原发性肝癌诊疗规范》基础上的更新。最重要的特征是增加了肝癌分期以方便临床使用，此外这个规范主要依据来自中国学者的经验和研究结果使之更为适合中国肝癌患者的特点，而且重视多学科联合诊治。这个规范还特别强调循证医学的证据支持，依据牛津版的循证医学等级标注每个推荐意见的证据级别。

作者： 复旦大学附属中山医院肝脏外科 孙惠川 王征 周俭 樊嘉

 

拓展指南：与肝癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017年版中国肝癌诊断和治疗规范解读)] GetToolGuiderByIdResponse(projectId=1, id=134901c0015e15a3, title=2017年版中国肝癌诊断和治疗规范解读, enTitle=, guiderFrom=实用肿瘤杂志.2018,33(1):1-3., authorId=null, author=, summary=2017 年原发性肝癌诊疗规范( 简称规范) 已由中国国家卫生与计划生育委员会( 国家卫计委) 公布，并建议各医院遵照实施。这个规范是在2011年中国国家卫生部组织编写的《原发性肝癌诊疗规范》基础上的更新。最重要的特征是增加了肝癌分期以方便临床使用，此外这个规范主要依据来自中国学者的经验和研究结果使之更为适合中国肝癌患者的特点，而且重视多学科联合诊治。这个规范还特别强调循证医学的证据支持，依据牛津, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2017 年原发性肝癌诊疗规范( 简称规范) 已由中国国家卫生与计划生育委员会( 国家卫计委) 公布，并建议各医院遵照实施。这个规范是在2011年中国国家卫生部组织编写的《原发性肝癌诊疗规范》基础上的更新。最重要的特征是增加了肝癌分期以方便临床使用，此外这个规范主要依据来自中国学者的经验和研究结果使之更为适合中国肝癌患者的特点，而且重视多学科联合诊治。这个规范还特别强调循证医学的证据支持，依据牛津版的循证医学等级标注每个推荐意见的证据级别。 </P>作者： 复旦大学附属中山医院肝脏外科 孙惠川 王征 周俭 樊嘉 <P> </P>拓展指南：<strong>与<font color=red>肝癌</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=262c41c00150068d" title="原发性肝癌诊疗规范（2017 年版）更新解读" target=_blank>原发性肝癌诊疗规范（2017 年版）更新解读</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=515471c001500073" title="《原发性肝癌诊疗规范（2017年版）》解读" target=_blank>《原发性肝癌诊疗规范（2017年版）》解读</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=b57171c001a625d1" title="原发性肝癌诊疗规范（2017年版）" target=_blank>原发性肝癌诊疗规范（2017年版）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=de96e1c001395235" title="【指南专题】3.18全国护肝日，踢开肝癌，最新肝癌指南汇总" target=_blank>【指南专题】3.18全国护肝日，踢开肝癌，最新肝癌指南汇总</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=1d92e1c00139a21e" title="《2014年韩国肝癌研究组及国立癌症中心肝细胞癌的管理实践指南》摘译" target=_blank>《2014年韩国肝癌研究组及国立癌症中心肝细胞癌的管理实践指南》摘译</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E8%82%9D%E7%99%8C" target=_blank>有关肝癌更多指南</a></ul>, tagList=[TagDto(tagId=1097, tagName=原发性肝癌), TagDto(tagId=1683, tagName=乌司他丁)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8431, appHits=910, showAppHits=0, pcHits=5271, showPcHits=3001, likes=102, shares=10, comments=12, approvalStatus=1, publishedTime=Sun Mar 25 22:37:34 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 25 22:37:34 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:50:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017年版中国肝癌诊断和治疗规范解读)])
2017年版中国肝癌诊断和治疗规范解读
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=946619, encodeId=1d2f946619a6, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/41378976434d42cb9f1a95092d0855fc/1f4092a3f3564d478e682a75953fa59d.jpg, createdBy=4c515225231, createdName=有治青年, createdTime=Mon Mar 08 23:50:41 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300240, encodeId=d921300240ab, content=值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 27 18:31:29 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300196, encodeId=c7553001967b, content=肝癌分期方便了临床使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue Mar 27 12:06:26 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299816, encodeId=632c29981603, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Mar 26 08:17:46 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299790, encodeId=57fa299e9037, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Mar 26 07:36:29 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2021-03-08 有治青年

    认真学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=946619, encodeId=1d2f946619a6, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/41378976434d42cb9f1a95092d0855fc/1f4092a3f3564d478e682a75953fa59d.jpg, createdBy=4c515225231, createdName=有治青年, createdTime=Mon Mar 08 23:50:41 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300240, encodeId=d921300240ab, content=值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 27 18:31:29 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300196, encodeId=c7553001967b, content=肝癌分期方便了临床使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue Mar 27 12:06:26 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299816, encodeId=632c29981603, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Mar 26 08:17:46 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299790, encodeId=57fa299e9037, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Mar 26 07:36:29 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-27 虈亣靌

    值得点赞!认真学习了.把经验应用于实践.为患者解除病痛.

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=946619, encodeId=1d2f946619a6, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/41378976434d42cb9f1a95092d0855fc/1f4092a3f3564d478e682a75953fa59d.jpg, createdBy=4c515225231, createdName=有治青年, createdTime=Mon Mar 08 23:50:41 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300240, encodeId=d921300240ab, content=值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 27 18:31:29 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300196, encodeId=c7553001967b, content=肝癌分期方便了临床使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue Mar 27 12:06:26 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299816, encodeId=632c29981603, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Mar 26 08:17:46 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299790, encodeId=57fa299e9037, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Mar 26 07:36:29 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-27 沉心多思

    肝癌分期方便了临床使用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=946619, encodeId=1d2f946619a6, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/41378976434d42cb9f1a95092d0855fc/1f4092a3f3564d478e682a75953fa59d.jpg, createdBy=4c515225231, createdName=有治青年, createdTime=Mon Mar 08 23:50:41 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300240, encodeId=d921300240ab, content=值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 27 18:31:29 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300196, encodeId=c7553001967b, content=肝癌分期方便了临床使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue Mar 27 12:06:26 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299816, encodeId=632c29981603, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Mar 26 08:17:46 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299790, encodeId=57fa299e9037, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Mar 26 07:36:29 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-26 龙胆草

    学习谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=946619, encodeId=1d2f946619a6, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/41378976434d42cb9f1a95092d0855fc/1f4092a3f3564d478e682a75953fa59d.jpg, createdBy=4c515225231, createdName=有治青年, createdTime=Mon Mar 08 23:50:41 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300240, encodeId=d921300240ab, content=值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Mar 27 18:31:29 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300196, encodeId=c7553001967b, content=肝癌分期方便了临床使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue Mar 27 12:06:26 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299816, encodeId=632c29981603, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Mar 26 08:17:46 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299790, encodeId=57fa299e9037, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Mar 26 07:36:29 CST 2018, time=2018-03-26, status=1, ipAttribution=)]
    2018-03-26 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

原发性肝癌诊疗规范（2017 年版）更新解读

暂未更新 · 2017-08-30

《原发性肝癌诊疗规范（2017年版）》解读

暂未更新 · 2017-09-15

《原发性肝癌规范化病理诊断指南（2015 年版）》解读

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2016-07-30

2016年原发性肝癌放疗共识

暂未更新 · 2016-11-30

2016 注射用洛铂在原发性肝癌TACE 治疗中的专家共识

中国医师协会介入医师分会 · 2016-09-30

Baidu
map
Baidu
map
Baidu
map